In colorectal cancer, tertiary lymphoid structures (TLSs) rich in B cells correlate with better immunotherapy outcomes; CCR10-CCL28 guides plasma cells from TLSs into tumor stroma, potentially contributing to tumor control (128). Here, CCL28 is linked to neoplasm.